Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 939.0 | 73 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 39.5 | 56 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 517.0 | 83 | |
N2586 | PI103 | 0.1 | uM | 3 | G-CSF | 10.5 | 86 | ||||
0 | G-CSF | 10.5 | 44 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | G-CSF | 18.0 | 61 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 23.0 | 48 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 20.0 | 79 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 18.0 | 71 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 22.0 | 80 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 13.0 | 56 | |
RA2159 | EO1428 | 1.0 | uM | 3 | G-CSF | 12.0 | 55 | ||||
N2586 | TNF-a | 100 | ng/mL | 3 | G-CSF | 26.5 | 84 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 25.5 | 68 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 35.0 | 72 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 17.0 | 66 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 15.0 | 64 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 30.5 | 76 | |
N2586 | EO1428 | 1.0 | uM | 3 | G-CSF | 9.0 | 52 | ||||
0 | G-CSF | 11.5 | 52 | ||||||||
RA2159 | 3 | G-CSF | 9.0 | 68 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | G-CSF | 10.0 | 63 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | G-CSF | 9.5 | 76 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | G-CSF | 8.0 | 75 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 8.0 | 38 |